For the analyses of normal prostate and prostate tumors, we used an antibody (Abcam ab33029) recommended for IHC studies that we also validated for the detection of endogenous HIC1 proteins by immunoblotting (Figure 2A). The gene discussed is HIC1; the disease is prostate neoplasm.